Literature DB >> 16557881

In Vivo Studies with the Partially Purified Protease (Elastase) from Pseudomonas aeruginosa.

G Meinke1, J Barum, B Rosenberg, R Berk.   

Abstract

An extracellular protease from Pseudomonas aeruginosa exhibiting elastase activity was characterized in vivo after an 80- to 100-fold purification by chemical and chromatographic procedures. The lethality of different samples for white, female mice was determined by intravenous, intranasal, intraperitoneal, and subcutaneous injections. The purified protease exhibited the following 48-hr LD(50) values: intraperitoneally, 9.0 protease units; intranasally, 31.5 protease units; and intranasally, 0.3 protease unit. In the concentrations tested no lethality was observed when the subcutaneous route was employed. Gross and microscopic studies revealed that purified protease was capable of eliciting a variety of tissue responses in mice depending upon its route of administration. Intraperitoneal injections resulted in gastrointestinal tract serosal hemorrhage and necrosis. Intranasal and intravenous injections produced pulmonary hemorrhage, whereas subcutaneous injections resulted in black, necrotic, ulcerating lesions.

Entities:  

Year:  1970        PMID: 16557881      PMCID: PMC416054          DOI: 10.1128/iai.2.5.583-589.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  RESPIRATORY TRACT BACTERIOLOGY IN CYSTIC FIBROSIS.

Authors:  V F IACOCCA; M SIBINGA; G J BARBERO
Journal:  Am J Dis Child       Date:  1963-09

2.  Automatic analysis of tissue culture proteins with stable Folin reagents.

Authors:  B ZAK; J COHEN
Journal:  Clin Chim Acta       Date:  1961-09       Impact factor: 3.786

3.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

4.  Occurrence of serious bacterial infections since introduction of antibacterial agents.

Authors:  M FINLAND; W F JONES; M W BARNES
Journal:  J Am Med Assoc       Date:  1959-08-29

5.  Photometric method for estimation of elastase activity.

Authors:  L A SACHAR; K K WINTER; N SICHER; S FRANKEL
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

6.  Corneal ulcers produced by cell-free extracts of Pseudomonas aeruginosa.

Authors:  E FISHER; J H ALLEN
Journal:  Am J Ophthalmol       Date:  1958-07       Impact factor: 5.258

7.  Pseudomonas Vaccine I. Preparation and Assay.

Authors:  H F Laborde; C L de Fajardo
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

8.  The lethal events in experimental Pseudomonas aeruginosa infection of mice.

Authors:  P F Bartell; T E Orr; M Garcia
Journal:  J Infect Dis       Date:  1968-04       Impact factor: 5.226

9.  The extracellular protease from Pseudomonas aeruginosa exhibiting elastase activity.

Authors:  G G Johnson; J M Morris; R S Berk
Journal:  Can J Microbiol       Date:  1967-06       Impact factor: 2.419

10.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

View more
  19 in total

1.  NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.

Authors:  B H Iglewski; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  [Inhibition of blood coagulation in vitro by protease of Pseudomonas aeruginosa].

Authors:  W Scharmann; W Kraft
Journal:  Blut       Date:  1974-02

3.  Separation of two hemolysins from Aeromonas hydrophila by isoelectric focusing.

Authors:  B Wretlind; R Möllby; T Wadström
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

4.  In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.

Authors:  R S Berk; D Brown; I Coutinho; D Meyers
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

5.  Comparison of two methods of genetic exchange in determination of the genetic locus of the structural gene for Pseudomonas aeruginosa elastase.

Authors:  T R Howe; B Wretlind; B H Iglewski
Journal:  J Bacteriol       Date:  1983-10       Impact factor: 3.490

6.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

7.  In vivo studies with collagenase from Pseudomonas aeruginosa.

Authors:  B Diener; L Carrick; R S Berk
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

8.  Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

Authors:  M Pollack; L T Callahan; N S Taylor
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Pseudomonas aeruginosa enzyme profiling: predictor of potential invasiveness and use as an epidemiological tool.

Authors:  J M Janda; E J Bottone
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

10.  Effects of metals on elastase from Pseudomonas aeruginosa SES-938-1.

Authors:  S Kocabiyik; E Ergin; S Turkoglu
Journal:  Biol Trace Elem Res       Date:  1995-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.